Abemaciclib API is used in the treatment of advanced or metastatic breast cancer (ABC/MBC) and hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced or metastatic non-small cell lung cancer (NSCLC).
https://www.qingmupharm.com/products/human-apis/abemaciclib-api